About
Basic Data Updated:
30 days agoTransgene Biotek Limited is a biotechnology company that operates transgene medical centers. The company's various segments, including diagnostic services, CRO services, and API-DHA, ensure a comprehensive range of services. A diverse portfolio of products is offered by the company, covering areas such as oncology, auto-immunity, drug delivery, and biogenerics. Among its oncology products are TBL-0404, used for treating metastatic liver cancer, TBL-0905 for metastatic breast cancer, and TBL-0306C for colon cancer. The company also offers auto-immunity products such as TBL-1203HI for HIV treatment and TBL-1108MS for multiple sclerosis. Its drug delivery products include TBL-1002OI for oral insulin delivery and TBL-1004HI for oral HIV drug delivery. Additionally, the company's biogenerics products, including tacrolimus, orlistat, and docosahexaenoic acid, provide effective solutions for various medical conditions.
Industry
Company Details
- Location
Medak, Telangana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | L85195TG1990PLC011065 |
| Company No. | 011065 |
| Stock Symbol | BSE : 526139 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 01 Mar 1990 |
| Date of AGM | 30 Dec 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Listed |
| ROC Code | Roc Hyderabad |
Financials of Transgene Biotek Limited.
Transgene Biotek Limited., for the financial year ended 2022, experienced significant reduction in revenue, with a 31.44% decrease. The company also saw a slight improvement in profitability, with a 0.3% increase in profit. The company's net worth observed a substantial decline by a decrease of 104%.
Corporate Structure
Unlock access to Transgene Biotek's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Transgene Biotek Limited.
Unlock and access historical data on people associated with Transgene Biotek, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
KR
Kollipara Rao
Managing DirectorAppointment Date: 01-Mar-1990
Status: Current
CP
Chowdari Prasad CFOAppointment Date: 24-May-2019
Status: Current
AJ
Ankita Jain Company SecretaryAppointment Date: 24-May-2019
Status: Current
Board Members(3)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Department Of Biotechnology Creation Date: 08 Apr 2010 | ₹5.07 Cr | Open |
Ge Capital Services India Creation Date: 30 Jul 2008 | ₹0.86 M | Open |
The Karur Vysya Bank Ltd. Creation Date: 30 May 2005 | ₹5.94 M | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Transgene Biotek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transgene Biotek's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
3 years 2 months Recent activity within the organization
Annual General Meeting
Transgene Biotek Limited. last Annual general meeting of members was held on 30 Dec 2023 as per latest MCA records.
30 Dec 2023Balance Sheet
Transgene Biotek Limited. has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Charges
A charge registered on 23 May 2007 via Charge ID 10052981 with Union Bank Of India was fully satisfied on 25 May 2021.
25 May 2021Director Appointment
Swetha Marri was appointed as a Director was appointed as a Director on 03 Jun 2020 & has been associated with this company since 3 years 11 months .
03 Jun 2020Director Appointment
Santhosh Kumar was appointed as a Director was appointed as a Director on 12 Nov 2019 & has been associated with this company since 4 years 6 months .
12 Nov 2019
Recent News, Updates & Announcement
Fund Diversion Case SEBI restricts Transgene Biotek 6 others from securities market.Besides Transgene will continue the measures to recall the outstanding amount of USD 385 million and bring the money back into its bank account in India within a period of one year from the date .
Business Medical Dialogues 02 Sep 2019
- Transgene A Positive 2018 Moving Ahead with a Strong Portfolio.
Transgene Euronext Paris TNG ParisTNG a biotech company that designs and develops virusbased immunotherapies to transform the fight against solid tumors and infectious diseases publishes its financial results for 2018 and provides an update on its clinical and preclinical portfolio and its technology platforms.
BioSpace 20 Mar 2019
- Transgene Biotek secures USA patent on oral Insulin technology.
Udaipurkiran 09 Jan 2019
- GDR issue Sebi lifts market ban on Transgene Bioteks 2 promoters director.
The latest ruling comes after Securities and Exchange Board of India Sebi in November 2014 had ordered a detailed probe in this regard .
PTI 08 Nov 2018
Frequently asked questions
What is the Incorporation or founding date of Transgene Biotek Limited.?
